Quality of life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR study

被引：0

作者：

Karthaus, M. ^{[1
]}

Kretzschmar, A. ^{[2
]}

Welslau, M. ^{[3
]}

Riera-Knorrenschild, J. ^{[4
]}

Kaiser, F. ^{[5
]}

Pelz, H. ^{[6
]}

Ettrich, T. ^{[7
]}

Lindig, U. ^{[8
]}

Schulz, H. ^{[9
]}

von Weikersthal, Fischer L. ^{[10
]}

Kisro, J. ^{[11
]}

de Wit, M. ^{[12
]}

Wiebe, S. ^{[13
]}

Koenigsmann, M. ^{[14
]}

Mahlberg, R. ^{[15
]}

Fuxius, S. ^{[16
]}

Stehle, I ^{[17
]}

Kubicka, S. ^{[18
]}

Schuler, M. K. ^{[19
]}

Schnoy, E. ^{[20
]}

Ruessel, J. ^{[21
]}

Graefe, T. ^{[22
]}

Mayer, F. ^{[23
]}

Berres, M. L. ^{[24
]}

Kubin, T. ^{[25
]}

Heinemann, V ^{[26
]}

机构：

[1] Klinikum Neuperlach Klinikum Harlaching, Hamatol & Onkol, Munich, Germany

[2] MVZ Mitte, Leipzig, Germany

[3] Praxis Hamatol & Onkol, Aschaffenburg, Germany

[4] Univ Klin, Giessen, Germany

[5] Praxis Hamatol & Onkol, Landshut, Germany

[6] Ambulantes Therapiezentrum Hamatol & Onkol, Offenburg, Germany

[7] Univ Klin Innere Med, Ulm, Germany

[8] Univ Jena, Med Klin 2, Jena, Germany

[9] PIOH Praxis Internist Onkol & Hamatol, Frechen, Germany

[10] Gesundheitszentrum St Marien, Amberg, Germany

[11] Onkol Schwerpunktpraxis, Lubeck, Germany

[12] Klin Innere Med Hamatol Onkol & Palliat Med, Berlin, Germany

[13] MVZ Media Vita, Munster, Germany

[14] MediProjekt, Hannover, Germany

[15] Klinikum Borromaerinnen, Innere Med 1, Trier, Germany

[16] Tumor Ctr, Heidelberg, Germany

[17] IDGGQ, Kaiserslautern, Germany

[18] Klinikum Steinberg, Reutlingen, Germany

[19] MVZ Oskar Helene Heim, Berlin, Germany

[20] Klinikum Augsburg, Augsburg, Germany

[21] Carl von Basedow Klinikum, Merseburg, Germany

[22] Forsch Gesell Malignitat & Resultate, Hamburg, Germany

[23] Int Gemeinschaftspraxis, Friedrichshafen, Germany

[24] Univ Klin RWTH, Aachen, Germany

[25] Hamatol Onkol Klinikum Traunstein, Traunstein, Germany

[26] Med Klin III, Munich, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ep317

引用

页码：219 / 219

页数：1

共 50 条

[1] Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial
Weiss, L.
Karthaus, M.
Riera-Knorrenschild, J.
Kretzschmar, A.
Welslau, M.
Vehling-Kaiser, U.
Pelz, H.
Ettrich, T. J.
Hess, J.
Reislaender, T.
Klein, A.
Heinemann, V
ESMO OPEN, 2022, 7 (01)
[2] Patient-reported quality of life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: Interim results of the TALLISUR study.
Karthaus, Meinolf
Kretzschmar, Albrecht
Fuxius, Stefan
Knorrenschild, Jorge Riera
Kaiser, Florian
Mahlberg, Rolf
Welslau, Manfred
Pelz, Henning
Heinemann, Volker
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[3] Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial
Karthaus, Meinolf
Heinemann, Volker
Riera-Knorrenschild, Jorge
Kretzschmar, Albrecht
Welslau, Manfred
Kaiser, Ulrich
Pelz, Henning
Ettrich, Thomas J.
Held, Swantje
Kehmann, Linde
Hess, Juergen
Reislaender, Timo
Weiss, Lena
BMC CANCER, 2024, 24 (01)
[4] TALLISUR Phase IV study of trifluridine/tipiracil (FTD/TPI) in patients with pre-treated metastatic Colorectal Cancer (mCRC) - subgroup analysis
Karthaus, M.
Weiss, L.
Riera-Knorrenschild, J.
Kretschmar, A.
Welslau, M.
Vehling-Kaiser, U.
Pelz, H.
Ettrich, T.
Held, S.
Klein, A.
Hess, J.
Reislaender, T.
Heinemann, V.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 160 - 160
[5] Trifluridine/tipiracil (FTD/TPI) in extensively pre-treated metastatic colorectal cancer (mCRC) patients: Evaluation of prognostic subgroups of the TALLISUR study
Karthaus, Meinolf
Weiss, Lena
Riera-Knorrenschild, Jorge
Kretzschmar, Albrecht
Welslau, Manfred
Vehling-Kaiser, Ursula
Pelz, Henning
Ettrich, Thomas Jens
Held, Swantje
Kehrmann, Linde
Hess, Juergen
Reislaender, Timo
Heinemann, Volker
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[6] Efficacy and safety data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: Real-world data from the non-interventional TACTIC study
Semsek, D.
Kroening, H.
Goehler, T.
Decker, T.
Kojouharoff, G.
Lipke, J.
Moorahrend, E.
Hartmann, F.
Reislaender, T.
de Buhr, R.
Frank, M.
Hogrefe, C.
Marschner, N.
Potthoff, K.
Schwaner, I.
ANNALS OF ONCOLOGY, 2022, 33 : S266 - S267
[7] Quality of life in a real-world study of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
Cheung, W. Y.
Kavan, P.
Dolley, A.
CURRENT ONCOLOGY, 2020, 27 (05) : E451 - E458
[8] QUAlity of LIfe and survival of meTAStatic colorectal cancer patients treated with trifluridine-tipiracil (QUALITAS)
Hamers, P.
Vink, G.
Elferink, M.
Koopman, M.
May, A. M.
ANNALS OF ONCOLOGY, 2020, 31 : S434 - S435
[9] Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)
Hamers, Patricia A. H.
Vink, Geraldine R.
Elferink, Marloes A. G.
Stellato, Rebecca K.
Dijksterhuis, Willemieke P. M.
Punt, Cornelis J. A.
Koopman, Miriam
May, Anne M.
CLINICAL COLORECTAL CANCER, 2022, 21 (02) : 154 - 166
[10] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
Yoshiaki Fujimoto
Ryota Nakanishi
Mamoru Nukatsuka
Kazuaki Matsuoka
Koji Ando
Takeshi Wakasa
Hiroyuki Kitao
Eiji Oki
Yoshihiko Maehara
Masaki Mori
Cancer Chemotherapy and Pharmacology, 2020, 85 : 1029 - 1038

← 1 2 3 4 5 →